Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1204501-37-0	ethyl 5-chloro-7-fluoro-1H-indole-2-carboxylate CCOC(=O)C1=CC2=CC(=CC(=C2N1)F)Cl	C₁₁H₉ClFNO₂	241.64	98%	Click to inquire
1204669-67-9	3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride C1=CC(=C(C=C1N2C(=NOC2=O)C3=NON=C3NCCN)Br)F.Cl	C₁₂H₁₁BRClFN₆O₃	421.61	98%	Click to inquire
1204669-69-1	Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester CC(C)(C)OC(=O)NS(=O)(=O)NCCNC1=NON=C1C2=NOC(=O)N2C3=CC(=C(C=C3)F)Br	C₁₇H₁₉BRFN₇O₇S	564.3	98%	Click to inquire
1204707-71-0	N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3R)-3,4-dihydroxybutan-2-yl)amino)pyrimidin-4-yl)azetidine-1-sulfonamide CC(C(CO)O)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)F)F)NS(=O)(=O)N3CCC3	C₁₈H₂₃F₂N₅O₄S₂	475.5	98%	Click to inquire
1204707-73-2	N-[2-[(2,3-difluorophenyl)methylsulfanyl]-6-[[(2S,3R)-3,4-dihydroxybutan-2-yl]amino]pyrimidin-4-yl]azetidine-1-sulfonamide CC(C(CO)O)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)F)F)NS(=O)(=O)N3CCC3	C₁₈H₂₃F₂N₅O₄S₂	475.5	99%	Click to inquire
1205749-53-6	tert-Butyl N-(3-cyanopyrrolidin-3-yl)carbamate CC(C)(C)OC(=O)NC1(CCNC1)C#N	C₁₀H₁₇N₃O₂	211.26	98%	Click to inquire
1206123-37-6	Etrasimod C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F	C₂₆H₂₆F₃NO₃	457.5	99%	Click to inquire
1206163-45-2	Solcitinib CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C	C₂₂H₂₃N₅O₂	389.4	99%	Click to inquire
120635-25-8	Mofegiline hydrochloride C1=CC(=CC=C1CCC(=CF)CN)F.Cl	C₁₁H₁₄ClF₂N	233.68	97%	Click to inquire
1206524-79-9	1,2-Pyrrolidinedicarboxylic acid, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, 1-(1,1-dimethylethyl) 2-methyl ester,(2S,4R)- CC(C)(C)OC(=O)N1CC(CC1C(=O)OC)OC2=NC3=C(C=CC(=C3)OC)N=C2Cl	C₂₀H₂₄ClN₃O₆	437.9	98%	Click to inquire

ethyl 5-chloro-7-fluoro-1H-indole-2-carboxylate

ethyl 5-chloro-7-fluoro-1H-indole-2-carboxylate

C₁₁H₉ClFNO₂ 241.64

3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride

1,2,4-Oxadiazol-5(4H)-one, 3-[4-[(2-aminoethyl)amino]-1,2,5-oxadiazol-3-yl]-4-(3-bromo-4-fluorophenyl)-, hydrochloride (1:1)

C₁₂H₁₁BRClFN₆O₃ 421.61

Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester

Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]a

C₁₇H₁₉BRFN₇O₇S 564.3

N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3R)-3,4-dihydroxybutan-2-yl)amino)pyrimidin-4-yl)azetidine-1-sulfonamide

C₁₈H₂₃F₂N₅O₄S₂ 475.5

N-[2-[(2,3-difluorophenyl)methylsulfanyl]-6-[[(2S,3R)-3,4-dihydroxybutan-2-yl]amino]pyrimidin-4-yl]azetidine-1-sulfonamide

C₁₈H₂₃F₂N₅O₄S₂ 475.5

tert-Butyl N-(3-cyanopyrrolidin-3-yl)carbamate

tert-Butyl N-(3-cyanopyrrolidin-3-yl)carbamate

C₁₀H₁₇N₃O₂ 211.26

C₂₆H₂₆F₃NO₃ 457.5

C₂₂H₂₃N₅O₂ 389.4

Mofegiline hydrochloride

Mofegiline hydrochloride

C₁₁H₁₄ClF₂N 233.68

1,2-Pyrrolidinedicarboxylic acid, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, 1-(1,1-dimethylethyl) 2-methyl ester,(2S,4R)-

C₂₀H₂₄ClN₃O₆ 437.9

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15162) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号